• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺炎:建立可靠动物模型的陷阱与障碍

Pneumonia: Pitfalls and Hindrances to Establishing a Reliable Animal Model.

作者信息

Chesnay Adélaïde, Paget Christophe, Heuzé-Vourc'h Nathalie, Baranek Thomas, Desoubeaux Guillaume

机构信息

Service de Parasitologie-Mycologie-Médecine Tropicale, Pôle Biologie Médicale, Hôpital Bretonneau, CHRU de Tours, 2 Boulevard Tonnellé, 37044 Tours, France.

Centre d'Etude des Pathologies Respiratoires (CEPR), Institut National de la Santé et de la Recherche Médicale U1100, Université de Tours, 10 Bouelvard Tonnellé, 37032 Tours, France.

出版信息

J Fungi (Basel). 2022 Jan 27;8(2):129. doi: 10.3390/jof8020129.

DOI:10.3390/jof8020129
PMID:35205883
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8877242/
Abstract

pneumonia is a severe lung infection that occurs primarily in largely immunocompromised patients. Few treatment options exist, and the mortality rate remains substantial. To develop new strategies in the fields of diagnosis and treatment, it appears to be critical to improve the scientific knowledge about the biology of the agent and the course of the disease. In the absence of in vitro continuous culture system, in vivo animal studies represent a crucial cornerstone for addressing pneumonia in laboratories. Here, we provide an overview of the animal models of pneumonia that were reported in the literature over the last 60 years. Overall, this review highlights the great heterogeneity of the variables studied: the choice of the host species and its genetics, the different immunosuppressive regimens to render an animal susceptible, the experimental challenge, and the different validation methods of the model. With this work, the investigator will have the keys to choose pivotal experimental parameters and major technical features that are assumed to likely influence the results according to the question asked. As an example, we propose an animal model to explore the immune response during pneumonia.

摘要

肺炎是一种主要发生在免疫功能严重受损患者中的严重肺部感染。治疗选择很少,死亡率仍然很高。为了在诊断和治疗领域开发新策略,提高对病原体生物学和疾病进程的科学认识似乎至关重要。由于缺乏体外连续培养系统,体内动物研究是实验室研究肺炎的关键基石。在此,我们概述了过去60年文献中报道的肺炎动物模型。总体而言,本综述强调了所研究变量的巨大异质性:宿主物种及其遗传学的选择、使动物易感性的不同免疫抑制方案、实验性攻击以及模型的不同验证方法。通过这项工作,研究人员将掌握根据所提问题选择可能影响结果的关键实验参数和主要技术特征的关键。例如,我们提出一种动物模型来探索肺炎期间的免疫反应。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3988/8877242/2598d5161a57/jof-08-00129-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3988/8877242/812211bbc804/jof-08-00129-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3988/8877242/03df9aaf7122/jof-08-00129-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3988/8877242/48190349892c/jof-08-00129-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3988/8877242/2598d5161a57/jof-08-00129-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3988/8877242/812211bbc804/jof-08-00129-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3988/8877242/03df9aaf7122/jof-08-00129-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3988/8877242/48190349892c/jof-08-00129-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3988/8877242/2598d5161a57/jof-08-00129-g004.jpg

相似文献

1
Pneumonia: Pitfalls and Hindrances to Establishing a Reliable Animal Model.肺炎:建立可靠动物模型的陷阱与障碍
J Fungi (Basel). 2022 Jan 27;8(2):129. doi: 10.3390/jof8020129.
2
Description of a Murine Model of Pneumocystis Pneumonia.描述一种用于肺囊虫肺炎的鼠类模型。
Mycopathologia. 2024 May 6;189(3):42. doi: 10.1007/s11046-024-00846-1.
3
Genetic Mouse Models of Pneumocystis Pneumonia.肺孢子菌肺炎的遗传小鼠模型。
Methods Mol Biol. 2023;2667:169-179. doi: 10.1007/978-1-0716-3199-7_13.
4
Pneumonia: Immunity, Vaccines, and Treatments.肺炎:免疫、疫苗与治疗
Pathogens. 2021 Feb 19;10(2):236. doi: 10.3390/pathogens10020236.
5
Animal pneumocystosis: a model for man.动物肺孢子菌病:人类疾病模型
Vet Res. 1999 Jan-Feb;30(1):1-26.
6
Clinical, Diagnostic, and Treatment Disparities between HIV-Infected and Non-HIV-Infected Immunocompromised Patients with Pneumocystis jirovecii Pneumonia.HIV 感染与非 HIV 感染免疫功能低下患者肺部卡氏肺孢子菌肺炎的临床、诊断和治疗差异。
Respiration. 2018;96(1):52-65. doi: 10.1159/000487713. Epub 2018 Apr 10.
7
[Pneumocystis Pneumonia in 107 HIV Infected Patients Admitted to the Department of Infectious Diseases at Santa Maria Hospital, Lisbon (2002 - 2013)].[107例人类免疫缺陷病毒感染患者的肺孢子菌肺炎,入住里斯本圣玛丽亚医院传染病科(2002 - 2013年)]
Acta Med Port. 2016 Oct;29(10):639-650. doi: 10.20344/amp.7022. Epub 2016 Oct 31.
8
Semiquantitative Real-Time PCR to Distinguish Pneumocystis Pneumonia from Colonization in a Heterogeneous Population of HIV-Negative Immunocompromised Patients.半定量实时 PCR 区分 HIV 阴性免疫抑制患者异质人群中的肺孢子菌肺炎与定植。
Microbiol Spectr. 2021 Sep 3;9(1):e0002621. doi: 10.1128/Spectrum.00026-21. Epub 2021 Aug 4.
9
promotes inflammasome formation and NETosis during pneumonia.促进肺炎期间的炎症小体形成和 NETosis。
mBio. 2024 Aug 14;15(8):e0140924. doi: 10.1128/mbio.01409-24. Epub 2024 Jul 2.
10
Treatment of Pneumocystis jirovecii pneumonia in HIV-infected patients: a review.HIV 感染者肺孢子菌肺炎的治疗:综述。
Expert Rev Anti Infect Ther. 2017 Sep;15(9):873-892. doi: 10.1080/14787210.2017.1364991. Epub 2017 Aug 21.

引用本文的文献

1
CD40 Expression by B Cells Is Required for Optimal Immunity to Murine Pneumocystis Infection.B 细胞表达 CD40 对于最佳的抗鼠肺囊虫感染免疫是必需的。
J Infect Dis. 2024 Oct 16;230(4):1033-1041. doi: 10.1093/infdis/jiae133.
2
CD40 Expression by B cells is Required for Optimal Immunity to Murine Infection.B细胞表达CD40是小鼠感染获得最佳免疫所必需的。
bioRxiv. 2024 Feb 5:2024.02.05.578900. doi: 10.1101/2024.02.05.578900.
3
Genetic Mouse Models of Pneumocystis Pneumonia.肺孢子菌肺炎的遗传小鼠模型。

本文引用的文献

1
The Effects of Sex and Strain on Fungal Burdens in Mice.性别和品系对小鼠真菌负荷的影响
J Fungi (Basel). 2022 Oct 19;8(10):1101. doi: 10.3390/jof8101101.
2
Retinoids in Fungal Infections: From Bench to Bedside.用于真菌感染的维甲酸:从实验台到病床
Pharmaceuticals (Basel). 2021 Sep 24;14(10):962. doi: 10.3390/ph14100962.
3
Genomic, microbial and environmental standardization in animal experimentation limiting immunological discovery.动物实验中的基因组、微生物和环境标准化限制了免疫学发现。
Methods Mol Biol. 2023;2667:169-179. doi: 10.1007/978-1-0716-3199-7_13.
BMC Immunol. 2020 Sep 2;21(1):50. doi: 10.1186/s12865-020-00380-x.
4
Hypersensitivity Reactions to Biologicals: from Bench to Bedside.生物制品的超敏反应:从实验室到临床
Curr Treat Options Allergy. 2020;7(1):71-83. doi: 10.1007/s40521-020-00242-2. Epub 2020 Jan 18.
5
Combination Immunotherapy with Passive Antibody and Sulfasalazine Accelerates Fungal Clearance and Promotes the Resolution of -Associated Immunopathogenesis.被动抗体联合柳氮磺吡啶治疗加速真菌清除并促进相关免疫发病机制的解决。
Infect Immun. 2020 Jan 22;88(2). doi: 10.1128/IAI.00640-19.
6
Combination of β-(1, 3)-D-glucan testing in serum and qPCR in nasopharyngeal aspirate for facilitated diagnosis of Pneumocystis jirovecii pneumonia.血清 β-(1, 3)-D-葡聚糖检测联合鼻咽抽吸物 qPCR 检测用于辅助诊断肺孢子菌肺炎。
Mycoses. 2019 Nov;62(11):1015-1022. doi: 10.1111/myc.12997. Epub 2019 Sep 18.
7
Transcriptomic and Proteomic Approaches to Finding Novel Diagnostic and Immunogenic Candidates in .基于转录组学和蛋白质组学的方法寻找. 中的新型诊断和免疫原性候选物
mSphere. 2019 Sep 4;4(5):e00488-19. doi: 10.1128/mSphere.00488-19.
8
Immunization with recombinant KEX1 induces robust and durable humoral responses in immunocompromised non-human primates.重组 KEX1 免疫可在免疫功能低下的非人灵长类动物中诱导强大而持久的体液应答。
Hum Vaccin Immunother. 2019;15(9):2075-2080. doi: 10.1080/21645515.2019.1631135. Epub 2019 Jul 26.
9
Clinical characteristics, treatment outcomes, and prognostic factors of pneumonia in non-HIV-infected patients.非HIV感染患者肺炎的临床特征、治疗结果及预后因素
Infect Drug Resist. 2019 May 30;12:1457-1467. doi: 10.2147/IDR.S199761. eCollection 2019.
10
Intrinsic Programming of Alveolar Macrophages for Protective Antifungal Innate Immunity Against Infection.肺泡巨噬细胞固有编程在保护性抗真菌感染固有免疫中的作用。
Front Immunol. 2018 Sep 19;9:2131. doi: 10.3389/fimmu.2018.02131. eCollection 2018.